EGFR (Epidermal Growth Factor Receptor)
EGFR
Receptor tyrosine kinase driving cell proliferation, commonly mutated in NSCLC.
İşlev
Activating mutations drive oncogenic signaling. Targeted by TKIs (erlotinib, osimertinib) and antibodies (cetuximab).
Bu Hedefe Etki Eden İlaçlar
| İlaç | Etki | Birincil |
|---|---|---|
| Trastuzumab | Antagonist | Evet |